CompletedNot Applicable

Assessing the Perioperative Outcomes of Minimally Invasive Posterior Approach Versus Direct Anterior Approach Total Hip Arthroplasty.

Italy50 participantsStarted 2022-04-28

Plain-language summary

The aim of the present study is to compare the early post-operative outcomes of minimally invasive posterolateral approach (Mis-PLA) Vs. direct anterior approach (DAA) in the treatment of primary hip osteoarthritis, with regards to blood loss and postoperative pain. Fifty patients treated with THA from 2022 to 2023 are randomly assigned to either receive Mis-PLA or DAA THA. Visual Analog Scale (VAS) is used to assess pain and recorder ad hospital admission and on postoperative days 1 and 3. Intraoperative and postoperative blood loss and blood transfusion rate are recorded, as well as operation time and length of stay (LOS).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * clinical and instrumented diagnosis of unilateral primary or secondary end-stage hip osteoarthritis candidate to total hip arthroplasty * patients with body mass index\<30 kg/m2, * absence of liver disease, coagulative pathology Exclusion Criteria: * patients with history of bleeding or thrombotic disorder, * patients with history of liver or renal disease * patients with anticoagulant or antiplatelet therapy * refusal to participate in the study

What they're measuring

Number of participants requiring blood tranfusions

Timeframe: preop to 3 days postop

Trial details

NCT IDNCT06659198

SponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-30

View on ClinicalTrials.gov More Total Hip Replacement Surgery trials